Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis

Neuropsychology. 2005 Jul;19(4):520-31. doi: 10.1037/0894-4105.19.4.520.


To determine the size of the impairment across different cognitive domains in preclinical Alzheimer's disease (AD), a meta-analysis based on 47 studies involving 9,097 controls and 1,207 preclinical AD cases was conducted. There were marked preclinical deficits in global cognitive ability, episodic memory, perceptual speed, and executive functioning; somewhat smaller deficits in verbal ability, visuospatial skill, and attention; and no preclinical impairment in primary memory. Younger age (< 75 years) and shorter follow-up intervals (< 3 years) were associated with larger effect sizes for both global cognitive ability and episodic memory. For global cognitive ability, studies that used population-based sampling yielded larger effect sizes; for episodic memory, larger differences were seen in studies that preidentified groups in terms of baseline cognitive impairment. Within episodic memory, delayed testing and recall-based assessment resulted in the largest effect sizes. The authors conclude that deficits in multiple cognitive domains are characteristic of AD several years before clinical diagnosis. The generalized nature of the deficit is consistent with recent observations that multiple brain structures and functions are affected long before the AD diagnosis.

Publication types

  • Comparative Study
  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Alzheimer Disease / complications*
  • Alzheimer Disease / diagnosis
  • Attention
  • Cognition / physiology*
  • Cognition Disorders / etiology*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Memory, Short-Term
  • Middle Aged
  • Neuropsychological Tests / statistics & numerical data
  • Psychiatric Status Rating Scales
  • Psychomotor Performance
  • Retrospective Studies
  • Sample Size
  • Space Perception
  • Statistics, Nonparametric